Comparing ceftazidime/avibactam and polymyxin B for treating carbapenem-resistant organisms infections: a propensity score-matched retrospective cohort study

•The outcome benefits of the CAZ/AVI group were different before and after matching.•No advantage of CAZ/AVI group over PMB group in mortality and clinical response.•The CAZ/AVI-based regimen is superior to PMB-based regimen in CRO eradication and in treating CRPA infections.•The CAZ/AVI monotherapy...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of antimicrobial agents 2024-12, p.107418, Article 107418
Hauptverfasser:	Liu, Chunmei, Leng, Bing, Xie, Maoyu, Jiang, Shuangyan, Guan, Xiaoyan, Xu, Jiahui, Guo, Yuqing, Jiang, Jinjiao, Zeng, Juan
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute kidney injury Carbapenem-resistant organisms Ceftazidime/avibactam Mortality Polymyxin B Propensity score matching
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!